64
CHARAFE-JAUFFRET, E.; TARPIN, C.; BARDOU, V.J.; BERTUCCI, F.; GINESTIER,
C.; BRAUD, A.C.; PUIG, B.; GENEIX, J.; HASSOUN, J.; BIRNBAUM, D.;
JACQUEMIER, J.; VIENS, P. Immunophenotypic analysis of inflammatory breast
cancers: identification of an “inflammatory signature”. Journal of Pathology,v. 202, p.
265-273, 2004.
CHARPIN, C.; GARCIA, S.; BOUVIER, C.; DEVICTOR, B.; ANDRAC, L.; CHOUX, R.;
LAVAUT, M. E-cadherin quantitative immunocytochemical assays in breast carcinomas.
Journal of Pathology, v. 181, p. 294-300, 1997.
COWIN, P.; ROWLANDS T.M.; HATSELL, S.J. Cadherins and catenins in breast
cancer. Current opinion in cell biology. v. 17, p. 499-508, 2005.
CULLEN, J.M.; PAGE, R.; MISDORP, W. An overview of cancer pathogenesis,
diagnosis, and management . In: MEUTEN, D.J. Tumors in Domestic Animal. 4.ed.
Iowa: Iowa State Press, p. 03-44, 2002.
DANIEL C.; STRICKLAND, P.; FRIEDMANN Y. Expression and functional role of E- and
P-cadherins in mouse mammary ductal morphogenesis and growth. Developmental
Biology, v. 169, p. 511-551, 1995.
DYCE, K. M.; SACK, W. O.; WENSING, C. J. G. Tratado de Anatomia Veterinária. 2
a
ed. Rio de Janeiro: Guanabara Koogan, 1996. p. 289-91.
GILLETT, C.E.; MILES, D.W.; RYDER, K.; SKILTON, D.; LIEBMAN, R.D.; SPRINGALL,
R.J.; BARNES, D.M.; HANBY, A.M. Retention of the expression of E-cadherin and
catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
Journal of Pathology, v. 193, p. 433-441, 2001.
GURIEC, N.; MARCELLIN, L.; GAIRARD, B.; CALDÉROLI, H.; WILK, A.; RENAUD, R.;
BERGERAT, J.P.; OBERLING, F. E-cadherin mRNA expression in breast carcinomas